4.3 Article

A loss-of-function mutation in PTCH1 suggests a role for autocrine hedgehog signaling in colorectal tumorigenesis

Journal

ONCOTARGET
Volume 4, Issue 12, Pages 2208-2211

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.1651

Keywords

Hedgehog; colorectal cancer; Patched; vismodegib; autocrine

Funding

  1. National Cancer Institute [R01CA157535, P30CA006973, P50CA062924]
  2. AACR-Fight Colorectal Cancer Fellowship

Ask authors/readers for more resources

Hedgehog (Hh) signaling is largely suppressed in the normal differentiated tissues of the adult but activated in many cancers. The Hh pathway can either be activated by the expression of Hh ligands, or by mutations that cause constitutive, ligand-independent signaling. Colorectal cancer cells frequently express Hh ligands that are believed to exert paracrine effects on the stromal component of the tumor. Evidence for a more direct role of Hh signaling on the growth and evolution of colorectal cancer cell clones has been lacking. Here, we report a loss-of-function mutation of PTCH1, a tumor suppressor in the Hh pathway, in a colorectal cancer that exhibits transcriptional upregulation of the downstream Hh gene GLI1. This finding demonstrates that autocrine Hh signaling can provide a selective advantage to evolving tumors that arise in the colorectal epithelia, and suggests a definable group of colorectal cancer patients that could derive enhanced benefit from Hh pathway inhibitors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Identification of Targetable ALK Rearrangements in Pancreatic Ductal Adenocarcinoma

Aatur D. Singhi, Siraj M. Ali, Jill Lacy, Andrew Hendifar, Khanh Nguyen, Jamie Koo, Jon H. Chung, Joel Greenbowe, Jeffrey S. Ross, Marina N. Nikiforova, Herbert J. Zeh, Inderpal S. Sarkaria, Anil Dasyam, Nathan Bahary

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)

Article Oncology

Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer

R. J. Hartmaier, S. E. Trabucco, N. Priedigkeit, J. H. Chung, C. A. Parachoniak, P. Vanden Borre, S. Morley, M. Rosenzweig, L. M. Gay, M. E. Goldberg, J. Suh, S. M. Ali, J. Ross, B. Leyland-Jones, B. Young, C. Williams, B. Park, M. Tsai, B. Haley, J. Peguero, R. D. Callahan, I. Sachelarie, J. Cho, J. M. Atkinson, A. Bahreini, A. M. Nagle, S. L. Puhalla, R. J. Watters, Z. Erdogan-Yildirim, L. Cao, S. Oesterreich, A. Mathew, P. C. Lucas, N. E. Davidson, A. M. Brufsky, G. M. Frampton, P. J. Stephens, J. Chmielecki, A. V. Lee

ANNALS OF ONCOLOGY (2018)

Article Oncology

BRCA2 Reversion Mutation Associated With Acquired Resistance to Olaparib in Estrogen Receptor-positive Breast Cancer Detected by Genomic Profiling of Tissue and Liquid Biopsy

Erica L. Gornstein, Sara Sandefur, Jon H. Chung, Laurie M. Gay, Oliver Holmes, Rachel L. Erlich, Salil Soman, L. Katherine Martin, Andrea V. Rose, Philip J. Stephens, Jeffrey S. Ross, Vincent A. Miller, Siraj M. Ali, Sibel Blau

CLINICAL BREAST CANCER (2018)

Article Oncology

Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or Anus

Alexa B. Schrock, Dean Pavlick, Samuel J. Klempner, Jon H. Chung, Brady Forcier, Allison Welsh, Lauren Young, Bryan Leyland-Jones, Rodolfo Bordoni, RichardD. Carvajal, Joseph Chao, Razelle Kurzrock, Jason K. Sicklick, Jeffrey S. Ross, Philip J. Stephens, Craig Devoe, Fadi Braiteh, Siraj M. Ali, Vincent A. Miller

CLINICAL CANCER RESEARCH (2018)

Letter Oncology

Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure

Andrea Necchi, Daniele Raggi, Patrizia Giannatempo, Alessandra Alessi, Gianluca Serafini, Maurizio Colecchia, Siraj M. Ali, Jon H. Chung

EUROPEAN JOURNAL OF CANCER (2018)

Letter Urology & Nephrology

Responses to Alectinib in ALK-rearranged Papillary Renal Cell Carcinoma

Sumanta K. Pal, Paulo Bergerot, Nazli Dizman, Cristiane Bergerot, Jacob Adashek, Russell Madison, Jon H. Chung, Siraj M. Ali, Jeremy O. Jones, Ravi Salgia

EUROPEAN UROLOGY (2018)

Article Urology & Nephrology

Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling

Sumanta K. Pal, Siraj M. Ali, Evgeny Yakirevich, Daniel M. Geynisman, Jose A. Karam, Julia A. Elvin, Garrett M. Frampton, Xuan Huang, Douglas I. Lin, Mark Rosenzweig, Doron Lipson, Philip J. Stephens, Jeffrey S. Ross, Vincent A. Miller, Neeraj Agarwal, Brian Shuch, Toni K. Choueiri, Jon H. Chung

EUROPEAN UROLOGY (2018)

Article Pathology

Analytical Validation of a Hybrid Capture-Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA

Travis A. Clark, Jon H. Chung, Mark Kennedy, Jason D. Hughes, Niru Chennagiri, Daniel S. Lieber, Bernard Fendler, Lauren Young, Mandy Zhao, Michael Coyne, Virginia Breese, Geneva Young, Amy Donahue, Dean Pavlick, Alyssa Tsiros, Timothy Brennan, Shan Zhong, Tariq Mughal, Mark Bailey, Jie He, Steven Roels, Garrett M. Frampton, Jill M. Spoerke, Steven Gendreau, Mark Lackner, Erica Schleifman, Eric Peters, Jeffrey S. Ross, Siraj M. Ali, Vincent A. Miller, Jeffrey P. Gregg, Philip J. Stephens, Allison Welsh, Geoff A. Otto, Doron Lipson

JOURNAL OF MOLECULAR DIAGNOSTICS (2018)

Article Oncology

Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy

Hyunseok Kang, Dean Pettinga, Adrian D. Schubert, Paul W. Ladenson, Douglas W. Ball, Jon H. Chung, Alexa B. Schrock, Russell Madison, Garrett M. Frampton, Phil J. Stephens, Jeffrey S. Ross, Vincent A. Miller, Siraj M. Ali

ONCOLOGIST (2019)

Article Multidisciplinary Sciences

RET rearrangements are actionable alterations in breast cancer

Bhavna S. Paratala, Jon H. Chung, Casey B. Williams, Bahar Yilmazel, Whitney Petrosky, Kirstin Williams, Alexa B. Schrock, Laurie M. Gay, Ellen Lee, Sonia C. Dolfi, Kien Pham, Stephanie Lin, Ming Yao, Atul Kulkarni, Frances DiClemente, Chen Liu, Lorna Rodriguez-Rodriguez, Shridar Ganesan, Jeffrey S. Ross, Siraj M. Ali, Brian Leyland-Jones, Kim M. Hirshfield

NATURE COMMUNICATIONS (2018)

Article Oncology

Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational Study

Steven E. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, John Reynolds, Megan L. Landsverk, Chun-Hung Chan, Morgan E. Nelson, Paul A. Thompson, Christie Ellison, Lora J. Black, James M. Ford, Jon H. Chung, Rachel Anhorn, Anu G. Gaba

JCO PRECISION ONCOLOGY (2018)

Article Oncology

Large-Cell Neuroendocrine Carcinoma of the Lung: A Focused Analysis of BRAF Alterations and Case Report of a BRAF Non-V600-Mutated Tumor Responding to Targeted Therapy

Young Kwang Chae, Keerthi B. Tamragouri, Jon Chung, Xiaoqi Lin, Vincent Miller, Siraj M. Ali, Francis J. Giles

JCO PRECISION ONCOLOGY (2018)

Article Oncology

Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer

J. H. Chung, D. Pavlick, R. Hartmaier, A. B. Schrock, L. Young, B. Forcier, P. Ye, M. K. Levin, M. Goldberg, H. Burris, L. M. Gay, A. D. Hoffman, P. J. Stephens, G. M. Frampton, D. M. Lipson, D. M. Nguyen, S. Ganesan, B. H. Park, L. T. Vahdat, B. Leyland-Jones, T. I. Mughal, L. Pusztai, J. O'Shaughnessy, V. A. Miller, J. S. Ross, S. M. Ali

ANNALS OF ONCOLOGY (2017)

Article Oncology

Comprehensive genomic profiling of malignant phyllodes tumors of the breast

Sahar Nozad, Christine E. Sheehan, Laurie M. Gay, Julia A. Elvin, Jo-Anne Vergilio, James Suh, Shakti Ramkissoon, Alexa B. Schrock, Kim M. Hirshfield, Nadia Ali, Shridar Ganesan, Siraj M. Ali, Vincent A. Miller, Philip J. Stephens, Jeffrey S. Ross, Jon H. Chung

BREAST CANCER RESEARCH AND TREATMENT (2017)

Article Oncology

Biallelic Deletion of PALB2 Occurs Across Multiple Tumor Types and Suggests Responsiveness to Poly (ADP-ribose) Polymerase Inhibition

Munveer S. Bhangoo, Carrie Costantini, Brian T. Clifford, Jon H. Chung, Alexa B. Schrock, Siraj M. Ali, Samuel J. Klempner

JCO PRECISION ONCOLOGY (2017)

No Data Available